Longitudinal Registry Including Patients Treated With Heavy Particles
CNAO REgistry triAL - REGAL
CNAO National Center of Oncological Hadrontherapy
3,000 participants
Jun 4, 2021
OBSERVATIONAL
Conditions
Summary
The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia. By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.
Eligibility
Inclusion Criteria2
- Patients treated with heavy particles at Fondazione CNAO, Pavia
- Patients who have the ability to understand and be willing to sign a written informed consent document
Exclusion Criteria1
- Patients or legal guardians who are unable to understand informed consent document
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Only data available from routine clinical practice at the National Center for Oncological Hadrontherapy (CNAO), based Pavia, will be collected. Intervention is not assigned.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05203250